布替萘芬对豚鼠皮肤真菌病的疗效观察

目的:观察布替萘芬乳膏剂及复方布替萘芬乳膏剂治疗豚鼠皮肤真菌病的疗效.方法;本实验共建立皮肤真菌病豚鼠感染模型54处,分别是1%布替萘芬乳膏治疗组,复方布替萘芬乳膏治疗组,l%萘替芬乳膏治疗组,1%联苯苄唑乳育治疗组,1%克霉唑软膏治疗组和空白对照组,疗程为14天,药物治疗结束后观察复发状况.结果:布替萘芬乳膏10天临床治愈率比联苯苄唑乳膏和萘替芬乳膏高22.3%,但无显著性差异(P>0.05),与克霉唑软膏差异有显著性意义(P<0.05).治愈后继续观察复发症状三周,布替萘芬复发数远小于其它各组药物.结论:布替萘芬作为抗皮肤浅表真菌药物有很好的发展前景.     

铁扇癣痒平凝胶剂治疗豚鼠皮肤真菌病的疗效观察

目的　观察铁扇癣痒平凝胶剂治疗豚鼠皮肤真菌病的疗效。方法　本试验用石膏样毛癣菌共建立皮肤真菌病豚鼠感染模型 10 8处 ,分别用铁扇癣痒平凝胶高低 2个剂量组、1%联苯苄唑凝胶和 1%克霉唑软膏进行治疗 ;并设凝胶基质和空白对照 ,疗程为 14d ,药物治疗结束后观察复发状况。结果　铁扇癣痒平凝胶 2个剂量组的 10d临床治愈率与 1%克霉唑软膏相比较 ,两者差异有显著性意义 (P <0 .0 5 ) ,与联苯苄唑凝胶的治疗作用相当 ;铁扇癣痒平凝胶与联苯苄唑凝胶的复发率与克霉唑软膏相比 ,有显著性差异 (P <0 .0 5 )。结论　铁扇癣痒平凝胶治疗豚鼠皮肤真菌病的疗效好 ,而且复发率低 ,作为抗皮肤浅表真菌药物有很好的发展前景。     

高效液相色谱法测定联苯苄唑乳膏中联苯苄唑的含量

目的　建立HPLC法测定联苯苄唑乳膏中联苯苄唑含量。方法　以十八烷基硅烷键合硅胶为填充剂 ,甲醇 -水 -四氢呋喃 (84∶15∶1)为流动相 ,检测波长 2 5 4nm。结果　联苯苄唑在 0 .0 10 0 7～ 0 .10 0 7mg·ml-1范围内线性关系良好 ;6次测定的平均回收率为 10 0 .32 % ,RSD 为 0 .35 %。结论　本法可用于测定联苯苄唑乳膏中联苯苄唑的含量     

口服特比萘芬加外用益康唑短程联合疗法治疗足癣的临床对照研究

目的评价口服特比萘芬片加外用益康唑乳膏短程联合疗法治疗足癣的疗效和安全性。方法采用随机数字表法将124名患者分为两组:试验组予特比萘芬片250mg口服,1次/d,联合益康唑乳膏外用,2次/d,共7d;对照组予益康唑乳膏外用,2次/d,同时口服维生素C片0.1g,1次/d,共28d。于停药时和停药后4周时观察临床疗效和真菌学疗效,停药后4周时观察复发情况。结果共有113例患者完成临床观察,脱落7例(试验组1例,对照组6例),剔除4例(对照组4例)。停药时两组相比试验组治愈率明显低于对照组(χ2=23.03,P<0.01),有效率及真菌清除率差异无统计学意义(χ2=0.33,P>0.05;χ2=0.03,P>0.05);停药后4周时两组相比试验组治愈率、有效率及真菌清除率均显著高于对照组(χ2=17.21,P<0.01;χ2=14.56,P<0.01;χ2=23.03,P<0.01);停药后4周时两组相比试验组复发率明显低于对照组(χ2=14.04,P<0.01);两组不良反应发生率相比差异无统计学意义(χ2=3.27,P>0.05)。结论口服特比萘芬片加外用益康唑乳膏短程联合疗法治疗足癣依从性和安全性高、疗效好。     

替芬泰对HepG2-2.2.15细胞HBV-DNA的抑制作用

目的探讨替芬泰对Hep G2-2.2.15细胞HBV-DNA的抑制作用。方法以Hep G2-2.2.15细胞作为实验模型,通过MTT法检测替芬泰对Hep G2-2.2.15细胞的毒性,确定替芬泰对Hep G2-2.2.15细胞的半数中毒浓度(TC50)。在替芬泰浓度为50μg·ml-1时未见明显的细胞毒性,所以设替芬泰3个剂量组为50、25、12.5μg·ml-1,拉米夫定50μg·ml-1作为阳性对照药,收集给药3、6 d的细胞。用实时荧光定量PCR法检测DNA载量。结果替芬泰对Hep G2-2.2.15细胞的TC50为180.70μg·ml-1。随着替芬泰药物浓度的增加,Hep G2-2.2.15细胞内的HBV-DNA拷贝数相应减少,并有明显的浓度依赖性。结论替芬泰对Hep G2-2.2.15细胞内HBV-DNA有显著的抑制作用,有效浓度为12.5μg·ml-1,最佳浓度为50μg·ml-1。     

大扶康注射液 大蒜油注射液对白色念珠菌的抗菌作用

目的　研究大扶康、大蒜油注射液对白色念珠菌的作用。方法　用沙氏培养基二倍稀释法测定药物对白色念珠菌的最小抑菌浓度 (MIC)、最小杀菌浓度 (MBC)值。采用菌落法绘制时间—杀菌曲线。用紫外分光光度法在 6 5 0nm测定吸收度值 ,经计算得药物的抗生素后效应 (PAE)值。结果　大扶康对白色念珠菌的MIC为 0 .78μg·ml-1,大蒜油注射液的MIC为 3.1μg·ml-1,MBC为 6 .2 μg·ml-1,PAE为 17h。结论　大扶康对白色念珠菌的作用表现为抑制真菌生长 ,且抑制作用强于大蒜油注射液。大蒜油注射液低浓度时为抑真菌作用 ,高浓度时为杀真菌作用 ,并具有长时间的PAE。提示 :两药联合使用 ,可发挥各自的特点。     

特比萘芬治疗皮肤真菌病21例

20 0 0年 9月～ 2 0 0 1年 2月 ,我们用特比萘芬片[山东齐鲁制药厂 ,(97)卫药准字Ｘ 12 9号 ]口服治疗皮肤真菌病 2 1例 ,疗效满意。1　临床资料1 1　一般情况　 2 1例均为门诊病人 ,男 13例 ,女 8例 ;年龄 15～ 63岁 ,平均 39岁。体癣、股癣 5例 ,手、足癣 10例 ,甲癣 6例。病程 8ｄ～ 2 1年。均具有典型临床表现 ,并经镜检或培养找到真菌而确诊 ,且 3个月内未系统用过抗真菌药 ,1个月内未外用过抗真菌药。患有全身衰竭 ,严重肝、肾功能不全 ,胃肠道疾病 ,免疫功能低下病人 ,以及妊娠、哺乳期妇女等 ,均不作为观察对象。1 2　方法　特比萘…     

血清芽管法检测白色念珠菌的药物敏感性实验

目的　了解呼吸道感染白色念珠菌对注射用抗真菌药物的敏感特性 ,为临床有效控制其感染提供依据。方法　采用改进的白色念珠菌芽管法药敏实验新方法 ,测定从呼吸道感染标本中分离出的 4 2株白色念珠菌对三种抗真菌药物的最低抑菌浓度 (MIC)。结果　氟康唑注射液、大蒜素注射液、黄柏提取物 ,在一定浓度下对呼吸道感染白色念珠菌有较明显的抑制作用。其MIC分别为 12 .5～ 2 0 0、0 .6 2 5～ 2 0、6 2 .5～ 5 0 0 μg·ml-1。结论　白色念珠菌芽管法药敏实验新方法 ,可为临床快速筛选敏感药物。     

非水滴定法测定盐酸萘替芬含量

目的：测定盐酸萘替芬的含量。方法：采用非水滴定法。结果：本法准确、重现性好。结论：本法可用于产品的质量控制,回收率为l00．11％,RSD 0.15％。     

萘替芬酮康唑治疗皮肤浅部真菌病60例

2008年3—10月，我们采用萘替芬酮康唑治疗皮肤浅部真菌病60例，疗效满意。现分析报告如下。1临床资料1．1一般情况60例中，男28例，女32例；年龄16～54岁，平均35岁。其中体真菌病9例，股真菌病17例，手真菌病13例，足真菌病21例。（1）纳入标准：临床诊断为体股真菌病、手足真菌病（不包括角化过度型）；真菌镜检阳性；获得患者的知情同意。     

The acutely limping child

Acute limping may be the result of multiple pathologies in children. The differential diagnosis varies based on the age of the child. Irrespective of age, the initial imaging work-up includes AP and frog leg radiographs of the pelvis and ultrasound; MRI may sometimes be helpful. In children less than 3 years, infections and trauma are most frequent. MRI is the imaging modality of choice when osteomyelitis is clinically suspected. Between the ages of 3 and 10 years, transient synovitis of the hip and Legg-Calvé-Perthes disease are main considerations but infection, inflammation and focal bony lesions are also considered. In children over 10 years, slipped capital femoral epiphysis also is considered.     

High Intensity Interval Training:New Insights

KEY POINTS ·High-intensity interval training(HIT)is characterized by repeated sessions of relatively brief，intermittent exercise.often performed with an“a11 out”effort or at an intensity close to that which elicits peak oxygen uptake(i.e.，≥90%of VO2 peak).     

Developmental validation of the PowerPlex(®) ESI 16 and PowerPlex(®) ESI 17 Systems: STR multiplexes for the new European standard

In response to the ENFSI and EDNAP groups’ call for new STR multiplexes for Europe, Promega^® developed a suite of four new DNA profiling kits. This paper describes the developmental validation study performed on the PowerPlex^® ESI 16 (European Standard Investigator 16) and the PowerPlex^® ESI 17 Systems. The PowerPlex^® ESI 16 System combines the 11 loci compatible with the UK National DNA Database^®, contained within the AmpFlSTR^® SGM Plus^® PCR Amplification Kit, with five additional loci: D2S441, D10S1248, D22S1045, D1S1656 and D12S391. The multiplex was designed to reduce the amplicon size of the loci found in the AmpFlSTR^® SGM Plus^® kit. This design facilitates increased robustness and amplification success for the loci used in the national DNA databases created in many countries, when analyzing degraded DNA samples. The PowerPlex^® ESI 17 System amplifies the same loci as the PowerPlex^® ESI 16 System, but with the addition of a primer pair for the SE33 locus. Tests were designed to address the developmental validation guidelines issued by the Scientific Working Group on DNA Analysis Methods (SWGDAM), and those of the DNA Advisory Board (DAB). Samples processed include DNA mixtures, PCR reactions spiked with inhibitors, a sensitivity series, and 306 United Kingdom donor samples to determine concordance with data generated with the AmpFlSTR^® SGM Plus^® kit. Allele frequencies from 242 white Caucasian samples collected in the United Kingdom are also presented. The PowerPlex^® ESI 16 and ESI 17 Systems are robust and sensitive tools, suitable for the analysis of forensic DNA samples. Full profiles were routinely observed with 62.5 pg of a fully heterozygous single source DNA template. This high level of sensitivity was found to impact on mixture analyses, where 54–86% of unique minor contributor alleles were routinely observed in a 1:19 mixture ratio. Improved sensitivity combined with the robustness afforded by smaller amplicons has substantially improved the quantity of data obtained from degraded samples, and the improved chemistry confers exceptional tolerance to high levels of laboratory prepared inhibitors.     

Bronchial stump fistula :treatment with covered retrievable hinged metallic stents-preliminary clinical experience

Objective To evaluate the preliminaily clinical efficacy and retrievability of a retrievable hinged covered metallic stent in the treatment of the bronchial stump fistula （BSF）. Methods Between April 2003 and March 2005, 8 patients with bronchial stump fistula after pneumonectomy or lobectomy were treated with two types （A and B） of retrievable hinged covered metallic stents. Type A stent was placed in 6 patients and type B in 2 under fluoroscopic guidance. The stent was removed with a retrieval set when BSF was healed or complications occurred. Results Stent placement in the bronchial tree was technically successful in all patients, without procedure-related complications. Immediate closure of the BSF was achieved in all patients after the procedure. Stents were removed from all patients but one. Removal of the stents was difficult in two patients due to tissue hyperplasia. Patients were followed up for 6 - 21 months. Placement of the stents remained stable in all patients except one due to severe cough. Permanent closure of BSF was achieved in 7 （87.5%） of 8 patients. Conclusion Use of a retrievable hinged covered expandable metallic stent is a simple, safe, and effective procedure for closure of the BSF. Retrieval of the stent seems to be feasible. （J Intervent Radiol, 2007, 16： 253-257）     

Die rechtsmedizinische Identifizierung — Bedeutung und Beweiswert —

Zusammenfassung Bei der rechtsmedizinischen Identifizierung kann die Identität im strengen Sinn allenfalls bei lebenden Personen festgestellt werden; sonst läßt sich nur von Teilen auf das Ganze (vom Untersuchungsobjekt auf die Person) schließen, wobei die verschiedenen Merkmale des Untersuchungsobjektes entsprechend der Hdufigkeit ihres Vorkommens eine unterschiedliche Beweiskraft haben. Bei der Schädelidentifizierung mit Hilfe moderner photographischer oder elektronischer Superprojektionsverfahren ergeben sich unter Berücksichtigung der Weichteildicken so viele (fiktive) Vergleichspunkte, daß bei geeignetem Vergleichsmaterial (Photographien) Identität wegen der Vielzahl übereinstimmender Bezugspunkte in den meisten Fällen evident ist.     

Imaging of abdominal nodal spread in malignant disease

This is a review of the role of imaging procedures for the assessment of abdominal and pelvic lymph nodes. The diagnosis of malignant lymphatic spread is rarely the sole purpose of imaging, because it is usually part of a general abdominal examination, most frequently with CT or US, or increasingly with MRI. These studies are often requested in order to obtain information about the situation to be encountered during surgery, or to alert the surgeon to irresectability or to unexpected metastases outside the initially planned area of exploration. In most surgically treated tumours the role of imaging for preoperative staging is limited, due either to its insufficient sensitivity or because the initial treatment is independent of the lymph node stage. Imaging is commonly used to verify treatment response to chemo- or radiotherapy and for follow-up.Correspondence to: S. Delorme     

改进的定位技术在胸部肿瘤穿刺活检中的应用

目的：探索CT-SIM三维定位系统、体模固定技术和PET-CT融合影像导引定位技术在胸部肿瘤经皮穿刺活检中的应用价值。方法：对380例胸部肿瘤患者行改进的CT定位技术下的经皮穿刺活检术。根据肿瘤的大小、深度、毗邻关系、活动度以及患者的心肺功能状态,综合运用CT-SIM系统、体模固定技术和PET-CT融合影像导引技术,为患者进行穿刺前定位。统计穿刺定位时间长度、成功率、确诊率、并发症发生情况,并与210例采用传统铅栅定位下胸部肿瘤穿刺活检的相应资料进行比较。结果：采用改进的CT定位技术的380例患者穿刺定位精确,平均定位时间（9.5 min）较传统方法（16.8 min）缩短7.3 min,活检成功率和确诊率分别是98.7%和95.3%,高于传统定位方法的93.3%和83.3%,两者差异均具有统计学意义（P〈0.05）。穿刺并发症发生率相似,气胸发生率分别为2.8%和2.9%,咯血发生率分别为11%和12.8%。结论：根据患者状态及肿瘤特点,在CT-SIM系统快速精确定位技术的基础上,综合运用体模固定技术和PET-CT融合影像导引技术,能显著缩短经皮穿刺活检的定位时间,提高活检成功率。